Microbleeds, Age Contribute to ARIA Risk With Aducanumab
Amyloid-related imaging abnormalities occurred in about 40% of participants in the phase 3 aducanumab studies ― and roughly one fourth of these experienced symptoms.
Source: medscape.com
Age Affect Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Age Affect Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Age Affect Risk Today - Breaking & Trending Today